Neurologia medico-chirurgica
Online ISSN : 1349-8029
Print ISSN : 0470-8105
ISSN-L : 0470-8105
Clinicopathological Study of High-dose Fractionated Radiation Therapy in the Treatment of Glioblastoma
Masaru TAMURA, Hiroshi INOUE, Hideo KUNIMINE, Masaru NAKAMURA, Nobuo ONO, Akira ZAMA, Chihiro OHYE, Hideo NIIBE, Yoichi ISHIDA
Author information
JOURNAL FREE ACCESS

1988 Volume 28 Issue 4 Pages 367-372

Details
Abstract
Twenty-six adults with glioblastoma multiforme (grade 4 astrocytoma) were postoperatively given high-dose fractionated radiation therapy (5 Gy twice weekly) with Linac X-rays. The results were compared with those in 26 patients treated by conventional fractionated radiation therapy (2 Gy 5 times weekly). The survival rates following treatment with high-dose fractionated radiation therapy and conventional fractionated radiation therapy were 65% vs. 65% at 1 year, 31% vs. 8% at 2 years, 14% vs. 4% at 3 years, and 4% vs. 0% at 5 years. The difference in length of survival between the two treatment groups was not statistically significant (p = 0.423). Autopsies were performed on 11 patients given high-dose radiation therapy and 13 who received conventional irradiation. In the high-dose group one patient had no residual tumor (vs. none in the conventional group) ; four had small residual tumors (vs. three) ; one had extensive coagulative necrosis of the tumor and surrounding brain tissue (vs. four) ; four had proliferative tumor growth (vs. four) ; and one had mixed glioblastoma and fibrosarcoma (vs. two). Complete cure may be possible in some cases, if extensive tumor removal is feasible and is followed by high-dose fractionated radiation therapy. The biological effect appears to be much greater with high-dose than with conventional fractionated radiation therapy. Therefore, in cases of tumor recurrence, a second course of radiation therapy must be undertaken cautiously.
Content from these authors
© The Japan Neurosurgical Society
Previous article Next article
feedback
Top